ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Mesenchymal Stem Cell Senescence and Rejuvenation: Current Status and Challenges

Zhou, Xueke; Hong, Yimei; Zhang, Hao; Li, Xin*广东省人民医院
Frontiers in Cell and Developmental Biology2020-6-3DOI: 10.3389/fcell.2020.00364
68被引6阅读
引用收藏
分享

摘要

Over the past decades, mesenchymal stem cell (MSC)-based therapy has been intensively investigated and shown promising results in the treatment of various diseases due to their easy isolation, multiple lineage differentiation potential and immunomodulatory effects. To date, hundreds of phase I and II clinical trials using MSCs have been completed and many are ongoing. Accumulating evidence has shown that transplanted allogeneic MSCs lose their beneficial effects due to immunorejection. Nevertheless, the function of autologous MSCs is adversely affected by age, a process termed senescence, thus limiting their therapeutic potential. Despite great advances in knowledge, the potential mechanisms underlying MSC senescence are not entirely clear. Understanding the molecular mechanisms that contribute to MSC senescence is crucial when exploring novel strategies to rejuvenate senescent MSCs. In this review, we aim to provide an overview of the biological features of senescent MSCs and the recent progress made regarding the underlying mechanisms including epigenetic changes, autophagy, mitochondrial dysfunction and telomere shortening. We also summarize the current approaches to rejuvenate senescent MSCs including gene modification and pretreatment strategies. Collectively, rejuvenation of senescent MSCs is a promising strategy to enhance the efficacy of autologous MSC-based therapy, especially in elderly patients.

学科与关键词

关键词
mesenchymal stem cellssenescenceautophagymitochondrialtelomererejuvenation
相关
加载中…
  • Senescent Mesenchymal Stem Cells in Myelodysplastic Syndrome: Functional Alterations, Molecular Mechanisms, and Therapeutic Strategies
    Chen, Xiaofang; Li, Ningyu; Weng, Jianyu; Du, Xin*Frontiers in Cell and Developmental Biology, 2021, 8: 617466.被引 8
  • Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges
    Li, Weifeng; Shi, Linli; Hu, Bei; Hong, Yimei; Zhang, Hao; Li, Xin*; Zhang, Yuelin*Frontiers in Cellular Neuroscience, 2021, 15: 628940.被引 35
  • Mesenchymal stromal cell therapy: Progress to date and future outlook
    Lu, Wen*; Allickson, JulieMolecular Therapy, 2025, 33(6): 2679-2688.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cell and Developmental Biology
发表日期
2020-06-03
卷期
第 8 卷
页码
364
DOI
10.3389/fcell.2020.00364
期刊收录
NSL.SCIE
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Grant of China [81871599, 81671882]; Tibet Autonomous Region Research Projects [XZ2018-01-GB-09]

作者

  • Z

    Zhou, Xueke (第一作者)

    guangdong prov peoples hosp

  • H

    Hong, Yimei

    guangdong prov peoples hosp

查看全部 4 位作者收起作者
  • Z

    Zhang, Hao

    bengbu med coll

  • L

    Li, Xin (通讯)

    guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417